Listed

NVP ASSOCIATES, LLC

An institutional investment manager in MENLO PARK, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 7, 2026. SEC CIK 1545692.

Share

Holdings: 7 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

NVP ASSOCIATES, LLC, holdings
IssuerClassCUSIPReported value$mWeightSharesPut or callChange on the quarter before
MBX Biosciences IncMBXCOM55287L10111835.9%2,136,335Unchanged
Avalyn Pharmaceuticals IncAVLNCOM SHS05348Y10574.722.8%2,268,404New+2,268,404
Omada Health IncOMDACOM68170A10855.616.9%2,531,000Unchanged
Zenas Biopharma IncZBIOCOM98937L10546.714.2%1,838,482Unchanged
Snowflake IncSNOWCOM SHS83344510929.28.9%114,786New+114,786
Grove Collaborative Hold IncGROVCOM CL A39957D2014.01.2%3,225,097Unchanged
Ondas IncONDSCOM NEW68236H2040.1<0.1%15,602New+15,602

Sold out: 1 position

Held at the end of the quarter before and not reported this quarter.

NVP ASSOCIATES, LLC, positions sold out
IssuerClassCUSIPReported value$WeightSharesPut or callChange on the quarter before
Billiontoone IncBLLNCL A0901681050.00.0%0Sold out−513,330

Source: SEC EDGAR, Form 13F-HR, accession 0001545692-26-000009 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.